Atlas Trials

Evaluate the Efficacy and Safety of Goofice® (Elobixibat) in Patients With Chronic Constipation

Clinical trial NCT05895877 · UNKNOWN

Trial details

NCT number
NCT05895877
Sponsor
Synmosa Biopharma Corp.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Constipation
Start date
2021-12-21
Primary completion
2023-09-30
Enrollment
351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.